Sector
PharmaceuticalsOpen
₹19.1Prev. Close
₹19.1Turnover(Lac.)
₹0.38Day's High
₹19.9Day's Low
₹18.7552 Week's High
₹4652 Week's Low
₹17.35Book Value
₹18.69Face Value
₹10Mkt Cap (₹ Cr.)
9.54P/E
16.51EPS
1.14Divi. Yield
019 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
9 Sep 2024
12:00 AM
AGM
Announcement Date: 09 Sep, 2024
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 5.09 | 5.09 | 5.09 | 5.09 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 3.83 | 2.97 | 2.2 | 2.84 |
Net Worth | 8.92 | 8.06 | 7.29 | 7.93 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 14.07 | 12.81 | 15.14 | 10.93 |
yoy growth (%) | 9.84 | -15.37 | 38.5 | -16.6 |
Raw materials | -7.41 | -6.6 | -9.27 | -6.49 |
As % of sales | 52.7 | 51.56 | 61.24 | 59.41 |
Employee costs | -1.17 | -0.96 | -0.77 | -1 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | -0.1 | 0.15 | 1.27 | -0.37 |
Depreciation | -1.27 | -0.65 | -0.32 | -0.37 |
Tax paid | -0.1 | -0.1 | -0.28 | -0.07 |
Working capital | 1.26 | -0.7 | 0.27 | -0.17 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 9.84 | -15.37 | 38.5 | -16.6 |
Op profit growth | 59.97 | -13.01 | -1,703.87 | -112.59 |
EBIT growth | -24.45 | -65.93 | -920.72 | -135.96 |
Net profit growth | 399.81 | -95.17 | -322.01 | -368.51 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.35 | 92.29 | 3,95,254.45 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,493.2 | 78.03 | 1,72,374.06 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,483.15 | 24.33 | 1,19,795.19 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,326.4 | 20.69 | 1,10,689.83 | 1,200.7 | 0.6 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,167.95 | 56.27 | 1,07,213.01 | 474 | 1.01 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Sanjay Sethi
Chairman & Non Executive Dir.
Sudhir Sethi
Independent Non Exe. Director
Abhinav Naik
Independent Non Exe. Director
Shreya Saraf
Company Sec. & Compli. Officer
Neha Sharma
133 Kanchan Bag,
Madhya Pradesh - 452001
Tel: 91-731-25076375/3046366
Website: http://www.beryldrugs.com
Email: beryldrugs25@yahoo.com
19/20 Jaferbhoy Ind,
1st Floor Makwana Rd, Marol Naka,
Mumbai - 400 059
Tel: 91-022-28594060
Website: www.adriotcorporate.com
Email: info@adroitcorporate.com
Summary
Beryl Drugs Limited, based in Indore, was incorporated on August 24, 1993. The Company acquired the running business of M/s Flora and Fauna Remedies Limited on December 15, 1993. The Shares of Company...
Read More
Reports by Beryl Drugs Ltd
What is the Beryl Drugs Ltd share price today?
What is the Market Cap of Beryl Drugs Ltd?
What is the PE and PB ratio of Beryl Drugs Ltd?
What is the 52 Week High and Low of Beryl Drugs Ltd?
What is the CAGR of Beryl Drugs Ltd?
What is the shareholding pattern of Beryl Drugs Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.